Skip to main content

Gout: Serum Urate Target (Recommended for eMeasure Trial Approval)

CBE ID
2549e
Endorsed
New or Maintenance
Endorsement and Maintenance (E&M) Cycle
Is Under Review
No
Measure Description

Percentage of patients aged 18 and older with a diagnosis of gout treated with urate-lowering therapy (ULT) for at least 12 months, whose most recent serum urate result is less than 6.8 mg/dL.

  • Most Recent Endorsement Activity
    Approved for Trial Use Musculoskeletal Endorsement Maintenance Project
    Initial Endorsement
    Endorsement Status
    Last Updated